These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

72 related articles for article (PubMed ID: 33853106)

  • 21. Discontinuation and relapse with paliperidone palmitate three-monthly for maintenance of schizophrenia: Two year follow-up of use in clinical practice.
    Wallman P; Clark I; Taylor D
    J Psychopharmacol; 2021 Sep; 35(9):1091-1098. PubMed ID: 33908302
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clinical Benefit and Utility of Switching to Aripiprazole Once Monthly in Patients with Antipsychotic Polypharmacy or Long Acting Injectable Antipsychotics for Patients with Schizophrenia in Routine Practice: A Retrospective, Observation Study.
    Pae CU; Han C; Bahk WM; Lee SJ; Patkar AA; Masand PS
    Clin Psychopharmacol Neurosci; 2021 May; 19(2):233-242. PubMed ID: 33888652
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Twenty-Year Trends in the Psychopharmacological Treatment of Outpatients with Borderline Personality Disorder: A Cross-Sectional Naturalistic Study in Spain.
    Pascual JC; Martín-Blanco A; Soler J
    CNS Drugs; 2021 Sep; 35(9):1023-1032. PubMed ID: 34370282
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current Clinical Psychopharmacology in Borderline Personality Disorder.
    Del Casale A; Bonanni L; Bargagna P; Novelli F; Fiaschè F; Paolini M; Forcina F; Anibaldi G; Cortese FN; Iannuccelli A; Adriani B; Brugnoli R; Girardi P; Paris J; Pompili M
    Curr Neuropharmacol; 2021; 19(10):1760-1779. PubMed ID: 34151763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Combination of Two Long-Acting Antipsychotics in Schizophrenia Spectrum Disorders: A Systematic Review.
    Cipolla S; Catapano P; D'Amico D; Monda R; Sallusto NP; Perris F; De Santis V; Catapano F; Luciano M; Fiorillo A
    Brain Sci; 2024 Apr; 14(5):. PubMed ID: 38790412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Preliminary data from a 4-year mirror-image and multicentre study of patients initiating paliperidone palmitate 6-monthly long-acting injectable antipsychotic: the Paliperidone 2 per Year study.
    García-Carmona JA; García-Pérez A; Isidro García G; Forcen-Muñoz LA; Ovejero García S; Sáez Povedano R; González-Galdámez AL; Mata Iturralde L; Hernández-Sánchez F; Ramirez Bonilla M; Fuentes-Pérez P; Ovejas-Catalán C; Suárez-Pinilla P; Valdivia-Muñoz F; Fernández Abascal B; Omaña Colmenares M; de Lourdes Martín-Pérez Á; Campos-Navarro MP; Baca-García E; Benavente-López S; Raya Platero A; Barberán Navalón M; Sánchez-Alonso S; Vázquez-Bourgon J; Pappa S
    Ther Adv Psychopharmacol; 2023; 13():20451253231220907. PubMed ID: 38152569
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Psychotropic medication use pre and post-diagnosis of cluster B personality disorder: a Quebec's health services register cohort.
    Lunghi C; Cailhol L; Massamba V; Laouan Sidi EA; Sirois C; Rahme E; Rochette L; Renaud S; Villeneuve E; Koch M; Biskin R; Martineau C; Vincent P; David P; Lesage A
    Front Psychiatry; 2023; 14():1243511. PubMed ID: 38076683
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cumulative Clinical Experience of the Use of Paliperidone Palmitate 3-Monthly Long-Acting Injection in the Treatment of Schizophrenia: A Critical Appraisal.
    García-Carmona JA; Pappa S
    Drug Healthc Patient Saf; 2023; 15():113-123. PubMed ID: 37720806
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical trajectories of individuals with severe mental illness continuing and discontinuing long-acting antipsychotics: a one-year mirror-image analysis from the STAR Network Depot study.
    Ostuzzi G; Tedeschi F; Bertolini F; Cotugno C; Aguglia A; Bartoli F; Carrà G; D'Agostino A; Martinotti G; Barbui C; Gastaldon C; Papola D
    Schizophrenia (Heidelb); 2023 Apr; 9(1):23. PubMed ID: 37069242
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Efficacy, acceptability and side-effects of oral versus long-acting- injectables antipsychotics: Systematic review and network meta-analysis.
    Wang D; Schneider-Thoma J; Siafis S; Qin M; Wu H; Zhu Y; Davis JM; Priller J; Leucht S
    Eur Neuropsychopharmacol; 2024 Jun; 83():11-18. PubMed ID: 38490016
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long-Acting Injections in Schizophrenia: a 3-Year Update on Randomized Controlled Trials Published January 2016-March 2019.
    Peters L; Krogmann A; von Hardenberg L; Bödeker K; Nöhles VB; Correll CU
    Curr Psychiatry Rep; 2019 Nov; 21(12):124. PubMed ID: 31745659
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Off-label use of second-generation antipsychotics in borderline personality disorder: a comparative real-world study among oral and long-acting injectables in Spain.
    García-Carmona JA; Simal-Aguado J; Campos-Navarro MP; Valdivia-Muñoz F; Galindo-Tovar A
    Int Clin Psychopharmacol; 2021 Jul; 36(4):201-207. PubMed ID: 33853106
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of long-acting injectable antipsychotics with the corresponding oral formulation in a cohort of patients with schizophrenia: a real-world study in Spain.
    García-Carmona JA; Simal-Aguado J; Campos-Navarro MP; Valdivia-Muñoz F; Galindo-Tovar A
    Int Clin Psychopharmacol; 2021 Jan; 36(1):18-24. PubMed ID: 33086252
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-Acting Injectable Antipsychotics: Analysis of Prescription Patterns and Patient Characteristics in Mental Health from a Spanish Real-World Study.
    García-Carmona JA; Simal-Aguado J; Campos-Navarro MP; Valdivia-Muñoz F; Galindo-Tovar A
    Clin Drug Investig; 2020 May; 40(5):459-468. PubMed ID: 32274654
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of 3-Monthly Long-Acting Injectable Paliperidone Palmitate in Schizophrenia: A Retrospective, Real-World Analysis of Population-Based Health Records in Spain.
    Gutiérrez-Rojas L; Sánchez-Alonso S; García Dorado M; López Rengel PM
    CNS Drugs; 2022 May; 36(5):517-527. PubMed ID: 35460508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment Patterns, Health Care Resource Utilization, and Spending in Medicaid Beneficiaries Initiating Second-generation Long-acting Injectable Agents Versus Oral Atypical Antipsychotics.
    Pilon D; Tandon N; Lafeuille MH; Kamstra R; Emond B; Lefebvre P; Joshi K
    Clin Ther; 2017 Oct; 39(10):1972-1985.e2. PubMed ID: 28919292
    [TBL] [Abstract][Full Text] [Related]  

  • 37.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 38.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.